Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011, Article ID 809378, 10 pages
http://dx.doi.org/10.4061/2011/809378
Research Article

Integrative Bioinformatics Analysis of Proteins Associated with the Cardiorenal Syndrome

1Emergentec Biodevelopment GmbH, Gersthofer Strasse 29-31, 1180 Vienna, Austria
2Department of Internal Medicine IV, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
3KH Elisabethinen Linz, Fadingerstrasse 1, 4010 Linz, Austria
4Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria

Received 19 August 2010; Accepted 17 September 2010

Academic Editor: Mitchell H. Rosner

Copyright © 2011 Irmgard Mühlberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Sarnak, A. S. Levey, A. C. Schoolwerth et al., “Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention,” Hypertension, vol. 42, no. 5, pp. 1050–1065, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo, “Cardiorenal Syndrome,” Journal of the American College of Cardiology, vol. 52, no. 19, pp. 1527–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Ronco, P. A. McCullough, S. D. Anker et al., “Cardiorenal syndromes: an executive summary from the consensus conference of the acute dialysis quality initiative (ADQI),” Contributions to Nephrology, vol. 165, pp. 54–67, 2010. View at Publisher · View at Google Scholar
  4. E. L. Schiffrin, M. L. Lipman, and J. F. E. Mann, “Chronic kidney disease: effects on the cardiovascular system,” Circulation, vol. 116, no. 1, pp. 85–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. S. Mahapatra, R. Lalmalsawma, N. P. Singh, M. Kumar, and S. C. Tiwari, “Cardiorenal syndrome,” Iranian Journal of Kidney Diseases, vol. 3, no. 2, pp. 61–70, 2009. View at Google Scholar · View at Scopus
  6. S. S. Soni, Y. Fahuan, C. Ronco, and D. N. Cruz, “Cardiorenal syndrome: biomarkers linking kidney damage with heart failure,” Biomarkers in Medicine, vol. 3, no. 5, pp. 549–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. O. M. Gutiérrez, J. L. Januzzi, T. Isakova et al., “Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease,” Circulation, vol. 119, no. 19, pp. 2545–2552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. W. Y. Chung, H. H. Clarice Yang, J. M. Kim et al., “Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease,” Circulation, vol. 120, no. 9, pp. 792–801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Perco, J. Wilflingseder, A. Bernthaler et al., “Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective,” Journal of Cellular and Molecular Medicine, vol. 12, no. 4, pp. 1177–1187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. J. Jensen, J. Saric, and P. Bork, “Literature mining for the biologist: from information retrieval to biological discovery,” Nature Reviews Genetics, vol. 7, no. 2, pp. 119–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Krallinger, A. Valencia, and L. Hirschman, “Linking genes to literature: text mining, information extraction, and retrieval applications for biology,” Genome Biology, vol. 9, no. 2, article S8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Yang, S. J. Adelstein, and A. I. Kassis, “Target discovery from data mining approaches,” Drug Discovery Today, vol. 14, no. 3-4, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Agarwal and D. B. Searls, “Literature mining in support of drug discovery,” Briefings in Bioinformatics, vol. 9, no. 6, pp. 479–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Altman, C. M. Bergman, J. Blake et al., “Text mining for biology—the way forward: opinions from leading scientists,” Genome Biology, vol. 9, no. 2, article S7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. D. Jani, G. L. Argraves, J. L. Barth, and W. S. Argraves, “GeneMesh: a web-based microarray analysis tool for relating differentially expressed genes to MeSH terms,” BMC Bioinformatics, vol. 11, article 166, 2010. View at Publisher · View at Google Scholar
  16. A. J. Lusis and J. N. Weiss, “Cardiovascular networks: systems-based approaches to cardiovascular disease,” Circulation, vol. 121, no. 1, pp. 157–170, 2010. View at Publisher · View at Google Scholar
  17. E. A. Ashley, R. Ferrara, J. Y. King et al., “Network analysis of human in-stent restenosis,” Circulation, vol. 114, no. 24, pp. 2644–2654, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K.-I. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal, and A.-L. Barabási, “The human disease network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8685–8690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Diez, A. M. Wheelock, S. Goto et al., “The use of network analyses for elucidating mechanisms in cardiovascular disease,” Molecular BioSystems, vol. 6, no. 2, pp. 289–304, 2010. View at Publisher · View at Google Scholar
  20. J. N. Weiss, L. Yang, and Z. Qu, “Thematic review series: systems biology approaches to metabolic and cardiovascular disorders: network perspectives of cardiovascular metabolism,” Journal of Lipid Research, vol. 47, no. 11, pp. 2355–2366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A.-L. Barabási and Z. N. Oltvai, “Network biology: understanding the cell's functional organization,” Nature Reviews Genetics, vol. 5, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Jeong, B. Tombor, R. Albert, Z. N. Oltval, and A.-L. Barabásl, “The large-scale organization of metabolic networks,” Nature, vol. 407, no. 6804, pp. 651–654, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Rizzuto, P. Pinton, W. Carrington et al., “Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses,” Science, vol. 280, no. 5370, pp. 1763–1766, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Vendelin, N. Béraud, K. Guerrero et al., “Mitochondrial regular arrangement in muscle cells: a “crystal-like” pattern,” American Journal of Physiology, vol. 288, no. 3, pp. C757–C767, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. L. H. Hartwell, J. J. Hopfield, S. Leibler, and A. W. Murray, “From molecular to modular cell biology,” Nature, vol. 402, no. 6761, pp. C47–C52, 1999. View at Google Scholar · View at Scopus
  26. B. O'Rourke, B. M. Ramza, and E. Marban, “Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells,” Science, vol. 265, no. 5174, pp. 962–966, 1994. View at Google Scholar · View at Scopus
  27. M. A. Aon, S. Cortassa, and B. O'Rourke, “Percolation and criticality in a mitochondrial network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4447–4452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Krallinger and A. Valencia, “Text-mining and information-retrieval services for molecular biology,” Genome Biology, vol. 6, no. 7, article 224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Hu, L. M. Hines, H. Weng et al., “Analysis of genomic and proteomic data using advanced literature mining,” Journal of Proteome Research, vol. 2, no. 4, pp. 405–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Crim, R. McDonald, and F. Pereira, “Automatically annotating documents with normalized gene lists,” BMC Bioinformatics, vol. 6, no. 1, article S13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. R. McDonald and F. Pereira, “Identifying gene and protein mentions in text using conditional random fields,” BMC Bioinformatics, vol. 6, no. 1, article S6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Diehn, G. Sherlock, G. Binkley et al., “SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data,” Nucleic Acids Research, vol. 31, no. 1, pp. 219–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. D. Thomas, M. J. Campbell, A. Kejariwal et al., “PANTHER: a library of protein families and subfamilies indexed by function,” Genome Research, vol. 13, no. 9, pp. 2129–2141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. P. D. Thomas, A. Kejariwal, N. Guo et al., “Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools,” Nucleic Acids Research, vol. 34, supplement 2, pp. W645–W650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Apweiler, A. Bairoch, C. H. Wu et al., “UniProt: the universal protein knowledgebase,” Nucleic Acids Research, vol. 32, supplement 1, pp. D115–D119, 2004. View at Google Scholar · View at Scopus
  36. P. Horton, K. J. Park, T. Obayashi et al., “WoLF PSORT: protein localization predictor,” Nucleic Acids Research, vol. 35, supplement 2, pp. W585–W587, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. D. Sehuler, “Pieces of use puzzle: expressed sequence tags and the catalog of human genes,” Journal of Molecular Medicine, vol. 75, no. 10, pp. 694–698, 1997. View at Google Scholar · View at Scopus
  38. A. Bernthaler, I. Mühlberger, R. Fechete, P. Perco, A. Lukas, and B. Mayer, “A dependency graph approach for the analysis of differential gene expression profiles,” Molecular BioSystems, vol. 5, no. 12, pp. 1720–1731, 2009. View at Publisher · View at Google Scholar
  39. D. S. Wishart, C. Knox, A. C. Guo et al., “DrugBank: a comprehensive resource for in silico drug discovery and exploration,” Nucleic Acids Research., vol. 34, supplement 1, pp. D668–D672, 2006. View at Google Scholar · View at Scopus
  40. D. S. Wishart, C. Knox, A. C. Guo et al., “DrugBank: a knowledgebase for drugs, drug actions and drug targets,” Nucleic Acids Research, vol. 36, supplement 1, pp. D901–D906, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. W. E. Judson and O. M. Helmer, “Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease,” Circulation, vol. 44, no. 2, pp. 245–253, 1971. View at Google Scholar · View at Scopus
  42. C. M. Ferrario, “Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control,” Life Sciences, vol. 86, no. 9-10, pp. 289–299, 2010. View at Publisher · View at Google Scholar
  43. S. I. McFarlane, N. Winer, and J. R. Sowers, “Role of the natriuretic peptide system in cardiorenal protection,” Archives of Internal Medicine, vol. 163, no. 22, pp. 2696–2704, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. D.-H. Kang, J. Hughes, M. Mazzali, G. F. Schreiner, and R. J. Johnson, “Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function,” Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1448–1457, 2001. View at Google Scholar · View at Scopus
  45. W. Risau, “Mechanisms of angiogenesis,” Nature, vol. 386, no. 6626, pp. 671–674, 1997. View at Google Scholar · View at Scopus
  46. M. Rudnicki, P. Perco, J. Enrich et al., “Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease,” Laboratory Investigation, vol. 89, no. 3, pp. 337–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. M. Witteles, D. Kao, D. Christopherson et al., “Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction. A randomized, double-blind, placebo-controlled clinical trial,” Journal of the American College of Cardiology, vol. 50, no. 19, pp. 1835–1840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Menne, C. Farsang, L. Deák et al., “Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial,” Journal of Hypertension, vol. 26, no. 9, pp. 1860–1867, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S.-S. Ding, C. Qiu, P. Hess, J.-F. Xi, J.-P. Clozel, and M. Clozel, “Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure,” Cardiovascular Research, vol. 53, no. 4, pp. 963–970, 2002. View at Publisher · View at Google Scholar · View at Scopus